starting with in vivo proof-of-concept testing to demonstrate the potential of its CT-02 molecular glues and CT-05 bifunctional degraders for autoimmune diseases, and more. As small molecules, CT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback